ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMGastos comerciales, generales y administrativos68.01 M130.41 M94.54 M91.65 M97.27 M413.86 MInvestigación y desarrollo——————Beneficio operativo391.46 M183.31 M302.79 M347.47 M433.75 M1.27 BTotal de ingresos no operativos——————Gastos por intereses, netos de intereses capitalizados——————Ingresos no operativos, una vez deducidos los gastos por intereses——————Ingresos/gastos extraordinarios——————Beneficio antes de impuestos102.88 M52.58 M76.48 M90.95 M122.91 M342.92 MParticipación en los beneficios——————Impuestos11.88 M-21.59 M15.04 M16 M23.73 M33.18 MParticipación minoritaria39.69 M20.15 M28.54 M35.12 M45.82 M129.62 MOtros ingresos/gastos después de impuestos-2.23 M210 K5.02 M1.24 M-2.54 M3.93 MBeneficio neto antes de actividades interrumpidas51.3 M54.02 M32.9 M39.84 M53.36 M180.12 MOperaciones suspendidas——————Beneficio neto51.3 M54.02 M32.9 M39.84 M53.36 M180.12 MAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas82.24 M88.63 M52.38 M65.25 M-15.09 M191.17 MBeneficio básico por acción2.022.121.261.552.077Beneficio por acción diluido1.841.991.221.491.986.68Número medio de acciones ordinarias25.45 M25.52 M25.68 M25.7 M25.72 M102.63 MAcciones diluidas44.11 M44.46 M43.95 M43.9 M28.61 M160.92 MEBITDA106.08 M55.79 M79.76 M94.36 M126.35 M356.26 MEBIT102.88 M52.58 M76.48 M90.95 M122.91 M342.92 MCosto de los ingresos——————Otros costes de producción——————Amortización y depreciación (flujo de caja)3.21 M3.21 M3.28 M3.41 M3.44 M13.34 M
PJT Partners Inc Class A
PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.
PJT operates businesses across strategic advisory, strategic capital markets, restructuring, shareholder advisory and capital raising. The firm has advised on over $1 trillion in M&A transactions including AbbVie's $63 billion acquisition of Allergan, T-Mobile's $59 billion merger with Sprint, and Mylan's $50 billion merger with Pfizer subsidiary, Upjohn.
The firm is headquartered in New York City, with additional offices in Boston, Chicago, Hong Kong, Houston, London, Los Angeles, Madrid, San Francisco and Sydney, and employs approximately 700 people.